Supplying our partners in the middle east
and neighboring markets with high quality, cost-effective, safe, and
reliable alternatives to branded medications, reducing
procurement costs while maintaining outcomes.
About Us
Genmed Pharma is a pharmaceutical distributor and
marketing affiliate based in Beirut, Lebanon, and serving the Middle East
with a primary commercial focus on the Iraqi market. Genmed Pharma
acts as the exclusive regional affiliate for a US-based parent company
headquartered in New York that specializes in high-quality, U.S. FDA–
approved generic medicines. Our business model combines the trust and
regulatory confidence of U.S. manufacturing standards with regional
market knowledge, local registration and distribution capability, and
competitive pricing.
Genmed Pharma’s core offering is the importation, registration, and
distribution of FDA–approved generic drugs across therapeutic classes
including cardiology, anti-infectives, neurology, endocrinology (including
diabetes care), gastrointestinal, pain management, and hospital injectable
portfolios. We aim to be the preferred partner for hospitals, chain
pharmacies, governmental procurement agencies, and private clinics in
Iraq and neighboring Middle East markets.
Product Highlights
Cardiovascular drugs
Antibiotics / Anti-infectives
Antivirals
Antifungals
Antidiabetic drugs
Gastrointestinal drugs
Analgesics / Painkiller
Anti-inflammatory drugs
CNS (Central Nervous System) drugs
Respiratory drugs
Anticancer (Oncology) drugs
Hormonal drugs
Immunosuppressant
Vitamins & Nutritional supplements
Purpose and Principles
Mission
To improve patient access to essential medicines across Iraq and
the Middle East by delivering high-quality, FDA–approved generics
through efficient distribution and trusted local partnerships.
Vision
To become the leading trusted supplier of premium generics in
Iraq and a recognized regional player known for quality,
compliance, and value.
Healthcare market is expanding with increased public procurement
and a large private pharmacy sector. Key market drivers include
rising chronic disease burdens (cardiovascular diseases and
diabetes), governmental hospital modernization plans, and
ongoing demand for affordable generics.
Prioritize Registrations
for high-demand products in the
private sector.
Bid
for hospital tenders and provide targeted value proposals
showing total-cost-savings vs branded equivalents.
Build Relationships
with local distributors and pharmacy
chains for last-mile reach.
Operation
Whole sale division supplying generic pharmaceutical to: